ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Zhongzhi Pharmaceutical Holdings Limited

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
1.18 ^HKD	-3.28%		-1.67%	-16.90%

Mar. 25	Zhongzhi Pharmaceutical's Attributable Jumps in 2023	MT
Mar. 22	Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024	CI

Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024

March 22, 2024 at 10:33 am EDT

Zhongzhi Pharmaceutical Holdings Limited proposed the payment of a final dividend of HKD 0.03 per share for the Year Ended 31 December 2023, Payable on 13 June 2024. Record date is 31 May 2024. Ex-dividend date is 24 May 2024.

Date of shareholders' approval: 17 May 2024.

Latest news about Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical's Attributable Jumps in 2023	Mar. 25	MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024	Mar. 22	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit	Jan. 25	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	Jan. 25	CI
Zhongzhi Pharmaceutical Holdings Limited Approves Interim Dividend	23-10-13	CI
Zhongzhi Pharmaceutical’s Profit Up 75% in H1	23-08-24	MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 2 November 2023	23-08-23	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7%	23-07-19	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023	23-07-19	CI
Zhongzhi Pharmaceutical Unit Chooses Builder for New Factory	23-05-23	MT
Zhongshan Hengsheng Enters into the Construction Contract with Shenzhen Xinmei	23-05-23	CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Special Dividend	23-05-18	CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend	23-05-18	CI
Zhongzhi Pharmaceutical Holdings Limited Proposes Special Dividend for the Year Ended 31 December 2022, Payable on 16 June 2023	23-03-22	CI
Zhongzhi Pharmaceutical Holdings Limited Proposes Payment of Final Dividend for the Year Ended 31 December 2022, Payable on 16 June 2023	23-03-22	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Zhongzhi Pharmaceutical Sees Twofold Jump in FY22 Profit	23-01-18	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022	23-01-18	CI
Zhongzhi Pharmaceutical Clocks Nearly 16% Jump in H1 Profit	22-08-26	MT
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24	CI
Zhongzhi Pharmaceutical Holdings Limited Announces Board Changes	22-03-24	CI
Zhongzhi Pharma Forecasts Lower Profit in 2021	22-02-22	MT

Chart Zhongzhi Pharmaceutical Holdings Limited

Duration

Period

Chart Zhongzhi Pharmaceutical Holdings Limited

More charts

Company Profile

Zhongzhi Pharmaceutical Holdings Ltd is a China-based investment holding company. The Company is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The Company operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in Zhongshan, Guangdong Province and operation of on-line pharmacies. The Companyâs brands include Zeus, Liumian and Caojinghua. The Company mainly conducts its businesses in the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED	-16.90%	135M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.81%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+13.30%	14.09B
CIPLA LIMITED	+12.97%	13.64B
ZYDUS LIFESCIENCES LIMITED	+39.74%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B

Generic Pharmaceuticals